Hub #2 β€” Step 1 Extensions

GI28 β€” Intestinal Pathology Case Review Step 1 Extensions

Clinical depth + mechanisms for USMLE Step 1 Β· 4 Learning Objectives Β· 54 drills

Source: GI28 Lecture Guide LOs: 1–4 (IBD β†’ Polyps & CRC)
Hub Progression: β†’ Hub 2 β€” Step 1 Extensions β†’
20
Flashcards
5
Ordering Drills
10
MCQ Items
5
Vignettes
8
Step 1 Traps
6
Reference Tables
Flashcard Progress 0 / 20 seen
LO 1 β€” Crohn Defining Features
What is the single pathologic hallmark that distinguishes Crohn disease from all other intestinal pathologies?
tap to flip
Answer
Non-caseating granulomas on a background of transmural inflammation. Present in ~35% of Crohn biopsies; MUST be non-caseating (no central necrosis) to distinguish from TB. Granulomas + transmural + skip lesions + crypt distortion = Crohn.
LO 1 β€” Crohn vs UC Complications
Which complication is pathognomonic for Crohn and never occurs in UC?
tap to flip
Answer
Perianal fistulas/abscesses. Occur in 25–30% of Crohn patients due to transmural (full-thickness) inflammation allowing sinus tracts. UC is mucosal-only β†’ no transmural penetration β†’ NO perianal fistulas. Also: enterovesical (pneumaturia), enteroenteric, enterocutaneous fistulas are Crohn-defining.
LO 1 β€” Smoking & IBD Paradox
How does smoking affect Crohn disease versus ulcerative colitis?
tap to flip
Answer
Smoking worsens Crohn (increase flares, complications, surgical recurrence) but is protective against UC (opposite effect). Mechanism unknown for UC protection; unclear if nicotine or combustion product. High-yield USMLE trap: "Smoking ↓ UC but ↑ Crohn disease."
LO 1 β€” UC Continuous Distribution
Why is rectal involvement mandatory in UC but often spared in Crohn disease?
tap to flip
Answer
UC always starts in rectum and extends proximally in one continuous swath. Rectum ALWAYS involved. In Crohn, skip lesions = discontinuous inflammation; rectal sparing is common (~20%). If rectal exam/sigmoidoscopy is normal in IBD + proximal colon inflammation β†’ think Crohn (skip to right colon) not UC.
LO 1 β€” B12 & Terminal Ileum
Why do Crohn patients with terminal ileal disease develop B12 deficiency?
tap to flip
Answer
The terminal ileum is the exclusive site of B12 (cobalamin) absorption via intrinsic factor-bound B12 binding to cubam receptors. Chronic Crohn inflammation/strictures of terminal ileum β†’ reduced absorption β†’ megaloblastic anemia. UC spares small bowel β†’ no B12 deficiency. Bile acid malabsorption also occurs in Crohn β†’ oxalate kidney stones.
LO 2 β€” C. difficile Toxins
Which toxin produced by C. difficile causes the pseudomembrane ("volcano lesion"), and which causes systemic toxicity?
tap to flip
Answer
Toxin A (enterotoxin) = mucosal damage β†’ pseudomembranes. Toxin B (cytotoxin) = cell rounding/death (seen in tissue culture) = systemic effects. Both contribute to disease; some strains produce only B (NAP1). Pseudomembrane = fibrin/neutrophils/epithelial debris coating mucosa.
LO 2 β€” CDI Risk: Four C's
Name four antibiotic classes that increase C. difficile infection risk, and explain why spore-forming dormancy is relevant.
tap to flip
Answer
Clindamycin, Cephalosporins, Fluoroquinolones, (+ Carbapenems, Penicillins). Broad-spectrum antibiotics kill protective anaerobic flora β†’ C. difficile (spore-former resistant to antibiotics) germinates β†’ toxin production. Spores survive in GI tract β†’ can persist months. Metronidazole is NO LONGER first-line; use oral vancomycin or fidaxomicin (IV flagyl does NOT reach colon).
LO 2 β€” CDI Testing Pearls
Why is 2-step testing recommended for C. difficile, and what happens with recurrence?
tap to flip
Answer
2-step = GDH or NAAT (sensitive, detects colonization) + toxin assay (toxin EIA = specific for toxigenic strains). GDH-only is NOT adequate. Recurrent CDI occurs in ~25% due to spore persistence; high-risk: age >65y, immunocompromised. Management: repeat vancomycin/fidaxomicin; consider fecal microbiota transplant (FMT) for β‰₯2 recurrences (cure rate >90%).
LO 3 β€” Diverticular Anatomy
Why are diverticula false diverticula in Western populations, and at what anatomic point do they occur?
tap to flip
Answer
False diverticula = outpouchings of mucosa + submucosa through the muscularis propria (NOT full-thickness). They occur at vasa recta penetration points where blood vessels weakly pierce the muscle. Sigmoid colon most common (narrow lumen = highest pressure by Laplace law). Low-fiber diet β†’ increased intraluminal pressure β†’ hernia at weak points.
LO 3 β€” Diverticulitis Complication: Fistula
What is the most common internal fistula from diverticulitis, and what is its classic presentation?
tap to flip
Answer
Colovesical fistula (colon β†’ bladder) most common. Classic presentation: pneumaturia (air in urine, "fizzy urine") or recurrent polymicrobial UTIs (fecal flora in bladder). Other fistulas: colovaginal (stool per vagina), cololileal. Pericolic abscess can also occur; hinchey grade IV = perforation with purulent peritonitis β†’ surgery.
LO 4 β€” Adenoma-Carcinoma Sequence
What is the classic molecular order of mutations in sporadic colorectal cancer, and why does this order matter?
tap to flip
Answer
APC loss (early) β†’ KRAS activation (intermediate) β†’ TP53 loss (late) in ~10-year progression. APC mutation = start; without it, no adenoma forms. "Adenoma-first" pathway explains why >10 years are needed (multi-step). IBD-CRC is OPPOSITE: p53 (early from inflammation) β†’ KRAS β†’ APC (late).
LO 4 β€” Sessile Serrated Adenomas
What genetic and epigenetic features distinguish sessile serrated polyps from tubular adenomas, and why are they high-risk?
tap to flip
Answer
Sessile serrated = BRAF mutation + CpG island methylator phenotype (CIMP) β†’ silencing of MLH1 (mismatch repair gene) β†’ microsatellite instability (MSI-H) β†’ high cancer risk. Sawtooth histology without dysplasia appears low-risk but progresses rapidly. Tubular = classic adenoma-carcinoma pathway (APC/KRAS/p53). MSI-H CRCs respond to pembrolizumab (anti-PD-1).
LO 4 β€” FAP Genetic & Clinical
What is the APC gene, what happens with germline mutations, and at what age must colectomy occur?
tap to flip
Answer
APC (adenomatous polyposis coli) = tumor suppressor on chr 5q. Germline mutation β†’ 100s–1000s of adenomatous polyps by age 10-20 β†’ 100% cancer risk by age 40 without intervention. Prophylactic total colectomy mandatory before age 20-25 (curative). Gardner syndrome = FAP + extraintestinal (osteomas, desmoids, congenital hypertrophy retinal pigment). Turcot = FAP + CNS tumors.
LO 4 β€” Lynch Syndrome (HNPCC)
What genes are mutated in Lynch syndrome, what is the surveillance approach, and what extracolonic cancer is most common?
tap to flip
Answer
Lynch = mismatch repair (MLH1, MSH2, MSH6, PMS2) mutations β†’ MSI-H. Colonoscopy every 1-2 years starting age 20-25. CRC typically right-sided, flat, younger (40-50y). Extracolonic cancers: endometrial (#1), ovarian, gastric, urothelial. Amsterdam criteria II = 3+ Lynch-associated cancers in 2+ generations, 1+ before age 50. Pembrolizumab for MSI-H metastatic CRC.
LO 4 β€” Right vs Left CRC Presentation
Why do right-sided CRCs typically present late with anemia, while left-sided present early with obstruction?
tap to flip
Answer
Right colon = wide lumen β†’ exophytic growth; blood loss is occult β†’ iron-deficiency anemia is first sign (can be severe before obstruction). Left colon = narrow lumen β†’ annular ("napkin-ring") constriction; early partial obstruction β†’ change in bowel habits, tenesmus. Right-sided often diagnosed at higher stage. Rectal/sigmoid exams may miss right-sided lesions β†’ colonoscopy mandatory for IDA + age β‰₯50y.
LO 4 β€” Peutz-Jeghers Syndrome
What is the genetic basis of Peutz-Jeghers, what are its cardinal features, and what cancers are at risk?
tap to flip
Answer
STK11/LKB1 mutation β†’ hamartomatous polyps throughout GI tract. Mucocutaneous pigmentation (dark macules on lips/buccal mucosa). Complications: intussusception (GI bleeding), obstruction. Cancer risk ↑↑: GI adenocarcinoma, breast, ovary, pancreas (~40% lifetime risk). Requires surveillance: upper/lower endoscopy + cross-sectional imaging, breast imaging, pancreatic screening.
LO 1 β€” PSC & UC Connection
What is primary sclerosing cholangitis (PSC), why is it linked to UC and not Crohn, and how does it affect CRC surveillance?
tap to flip
Answer
PSC = progressive bile duct fibrosis ("onion-skin") with strictures on MRCP/ERCP; p-ANCA positive. Occurs in ~5% of UC patients (rare in Crohn); mechanism unknown. Dramatically increases CRC risk β†’ annual colonoscopy from PSC diagnosis (not 7y+). Also increases cholangiocarcinoma risk; ursodeoxycholic acid may slow progression but not curative.
LO 1 β€” IBD Extraintestinal Manifestations
Name four extraintestinal manifestations of IBD and identify which are specific to Crohn or UC.
tap to flip
Answer
Erythema nodosum, pyoderma gangrenosum, uveitis, arthritis, PSC: both IBD types. Crohn-specific: perianal fistulas/abscesses. UC-linked: PSC more common. Calcium oxalate kidney stones = Crohn (fat/bile acid malabsorption). Ankylosing spondylitis/HLA-B27 = both; worse in HLA-B27+ patients.
Sequence Drills
Crohn Disease Natural History Evolution
Order the disease phenotypes from earliest to latest presentation. Drag items into sequence.
Penetrating disease (fistulas/abscesses)
Fibrostenotic disease (strictures)
Inflammatory (non-stricturing, non-penetrating)
Surgical intervention needed
Correct order:
  1. Inflammatory: ~70% at diagnosis; non-stricturing, non-penetrating
  2. Fibrostenotic: strictures develop over years from submucosal fibrosis
  3. Penetrating: deep transmural ulcers β†’ sinus tracts β†’ fistulas/abscesses
  4. Surgery: >50% need surgery within 10y; repeat resections for recurrence
C. difficile Infection & Treatment Cascade
Order the sequence from risk to treatment. Non-severe to severe cases may follow different paths.
Broad-spectrum antibiotic exposure
Flora dysbiosis + C. diff spore germination
Toxin A/B production + pseudomembrane
Oral vancomycin or fidaxomicin first-line
FMT for recurrence if β‰₯2 episodes
Correct order:
  1. Antibiotic exposure: clindamycin, cephalosporins, FQs, carbapenems kill protective anaerobes
  2. Dysbiosis: C. diff (spore-forming, antibiotic-resistant) replicates unopposed
  3. Toxin production: Toxin A (mucosal damage) + Toxin B (cytotoxin) β†’ pseudomembranes
  4. First-line Rx: Metronidazole is outdated; vancomycin (oral) or fidaxomicin (oral, preferred) are standard
  5. Recurrence Rx: FMT is gold standard for β‰₯2 recurrences (cure >90%)
Sporadic CRC Molecular Progression
Order the classic adenoma-carcinoma molecular sequence.
APC mutation (ch 5q loss)
KRAS activation
Adenoma formation
TP53 loss
Carcinoma evolution
Correct order:
  1. APC first: Wnt pathway activation; without APC loss, no adenoma forms
  2. Adenoma: Low-grade dysplasia (early adenoma)
  3. KRAS: Intermediate step; increased cell proliferation
  4. TP53: Loss of apoptosis checkpoint β†’ high-grade dysplasia
  5. Carcinoma: Invasion through basement membrane
Diverticulitis Severity Staging (Hinchey)
Order diverticulitis complications from mild to severe.
Pericolic or mesenteric abscess
Generalized purulent peritonitis (perforation into peritoneum)
Uncomplicated diverticulitis (no abscess, no perforation)
Generalized fecal peritonitis
Correct order (Hinchey staging):
  1. Grade 0–I: Uncomplicated (localized to colon)
  2. Grade II: Pericolic or mesenteric abscess (contained, treatable with IV Abx + drainage)
  3. Grade III: Purulent peritonitis (free pus in peritoneum; requires surgery)
  4. Grade IV: Fecal peritonitis (stool in peritoneum; highest mortality; emergency surgery)
IBD-Associated CRC Molecular (Inflammation-Dysplasia-Ca)
Order the molecular sequence of IBD-CRC (opposite to sporadic). Start with inflammation.
Chronic inflammation β†’ p53 mutations (early)
Flat dysplasia in inflamed mucosa
KRAS activation
APC loss (late)
Colorectal carcinoma
Correct order (IBD-CRC, inflammation-first):
  1. p53 first: Chronic inflammation causes DNA damage β†’ p53 mutations early (opposite sporadic)
  2. KRAS activation: Intermediate step
  3. APC loss: Late event (opposite sporadic where APC is first)
  4. Flat dysplasia: High-risk precursor (not polypoid like sporadic adenomas)
  5. Carcinoma: Often multifocal, mucinous/signet-ring morphology
Single Best Answer Questions
Q1
A 26-year-old man presents with 6 months of chronic RLQ pain, non-bloody diarrhea, and iron-deficiency anemia. Colonoscopy shows skip lesions in the terminal ileum and colon. Biopsy reveals transmural inflammation with non-caseating granulomas. Which genetic mutation is most associated with this disease?
A APC (chromosome 5q)
B NOD2/CARD15
C MLH1 (mismatch repair)
D BRCA1
E TP53
Correct: B β€” NOD2/CARD15
Explanation: Crohn disease is strongly associated with loss-of-function NOD2/CARD15 mutations (innate immune receptor for bacterial peptidoglycan recognition). This mutation is present in ~15% of Crohn patients and increases risk 15–40Γ—. Skip lesions + transmural + non-caseating granulomas = Crohn.
Distractors: APC = FAP, MLH1 = Lynch syndrome mismatch repair, BRCA1 = breast/ovarian cancer, TP53 = Li-Fraumeni. None of these cause IBD.
Q2
A 42-year-old woman with a 10-year history of pancolitis (ulcerative colitis) undergoes screening colonoscopy. Random biopsies show flat dysplasia in two colon segments without a visible polyp. Which of the following is the most appropriate next step?
A Repeat colonoscopy in 3 months with chromoendoscopy
B Total proctocolectomy
C Increase 5-ASA dosage and follow-up in 6 months
D Polypectomy of dysplastic segments
E Ursodeoxycholic acid for liver protection
Correct: B β€” Total proctocolectomy
Explanation: Flat dysplasia in UC is a high-risk lesion with ~30–40% chance of occult carcinoma in surgical specimen. It is non-polypoid β†’ cannot be resected endoscopically. Standard management is curative total proctocolectomy Β± ileoanal pouch (eliminates CRC risk entirely).
Distractors: Watchful waiting misses cancer. Polypectomy is inappropriate for flat dysplasia. ASA/UDCA don't prevent dysplasia progression. IBD-CRC is inflammation-driven; only colectomy is curative.
Q3
A 68-year-old hospitalized patient develops diarrhea 3 days after starting clindamycin for a skin infection. Stool toxin assay (EIA) is positive. Which of the following is the most appropriate first-line treatment for C. difficile infection?
A IV metronidazole + oral vancomycin
B Oral vancomycin or fidaxomicin
C Metronidazole PO monotherapy
D Loperamide to reduce diarrhea
E Fecal microbiota transplant immediately
Correct: B β€” Oral vancomycin or fidaxomicin
Explanation: Metronidazole is NO LONGER first-line. Oral vancomycin (non-absorbed) or fidaxomicin (preferred, lower recurrence) are standard. IV metronidazole does NOT reach the colon β†’ ineffective for CDI. FMT is reserved for β‰₯2 recurrences, not initial infection.
Distractors: Metronidazole outdated. Loperamide increases toxic megacolon risk β†’ contraindicated. IV therapy ineffective. FMT is second-line.
Q4
A 58-year-old man with a history of low-fiber diet and chronic constipation presents with left lower quadrant pain, fever, and leukocytosis. CT shows a 2 cm pericolic abscess. Which of the following is the most appropriate management?
A Immediate emergency surgery
B IV antibiotics + percutaneous drainage Β± repeat colonoscopy
C High-fiber diet + watchful waiting
D Metronidazole PO monotherapy
E Loperamide to reduce diarrhea
Correct: B β€” IV antibiotics + percutaneous drainage
Explanation: Hinchey Grade II (pericolic abscess <4 cm) is managed conservatively: IV broad-spectrum antibiotics + percutaneous CT-guided drainage. Surgery reserved for Grade III–IV (purulent/fecal peritonitis) or failed medical management.
Distractors: Immediate surgery is for perforation/peritonitis, not contained abscess. Watchful waiting alone risks sepsis. Monotherapy/antidiarrheals are inadequate for complicated diverticulitis.
Q5
A 55-year-old woman undergoing colonoscopy for iron-deficiency anemia is found to have a sessile polyp with sawtooth histology in the right colon. Biopsy shows BRAF mutation and CIMP. Which of the following best describes her cancer risk?
A Very low; benign finding requiring only follow-up
B Very high; rapidly progressing to carcinoma
C Standard adenoma risk; routine surveillance sufficient
D Low risk due to sawtooth appearance
E No cancer risk; only bleeding risk
Correct: B β€” Very high, rapidly progressive
Explanation: Sessile serrated polyps with BRAF + CIMP have HIGH cancer risk despite benign-appearing sawtooth histology. CIMP β†’ MLH1 silencing β†’ MSI-H β†’ rapid malignant transformation. Right-sided location adds to risk profile. Requires aggressive follow-up and resection.
Distractors: Sawtooth appearance is deceptively low-risk-looking but IS a trap. BRAF/CIMP signature confers high malignancy. Not routine adenoma risk.
Q6
A 22-year-old man with familial adenomatous polyposis (FAP) has just been diagnosed based on genetic testing. He currently has no symptoms. Which of the following is the most appropriate timing for prophylactic colectomy?
A After diagnosis of the first adenoma
B Before age 25–30 (ideally age 20–22)
C When symptoms develop (abdominal pain or bleeding)
D After age 40 if no cancer detected
E Never, surveillance colonoscopy is sufficient
Correct: B β€” Before age 25–30
Explanation: FAP patients have 100% colon cancer risk by age 40 without intervention. Prophylactic total colectomy is curative and is recommended BEFORE age 25–30 (ideally age 20–25 for young adults with genetic testing). Thousands of polyps develop by age 10–20.
Distractors: Waiting for cancer or symptoms misses the window. Surveillance alone cannot prevent cancer (too many polyps, too high risk). APC germline mutations guarantee polyps β†’ polyps guarantee cancer progression.
Q7
A 35-year-old woman is found to have a right-sided colon cancer with microsatellite instability-high (MSI-H). Genetic testing reveals mutations in mismatch repair genes. Which of the following is most likely?
A Sporadic CRC with APC mutations
B Lynch syndrome (HNPCC)
C Familial adenomatous polyposis
D Juvenile polyposis
E Inflammatory bowel disease-associated CRC
Correct: B β€” Lynch syndrome (HNPCC)
Explanation: Mismatch repair mutations (MLH1, MSH2, MSH6, PMS2) define Lynch syndrome. Young age at diagnosis, right-sided CRC, MSI-H, flat adenomas, and family history of CRC/endometrial/ovarian cancer β†’ Lynch. Screen siblings, offer colonoscopy every 1–2 years starting age 20–25.
Distractors: FAP = APC (not mismatch repair), usually presents with hundreds of polyps. Juvenile polyposis = SMAD4/BMPR1A. IBD-CRC typically has chronic IBD history.
Q8
A 28-year-old man with Crohn disease and 5 years of terminal ileal involvement develops recurrent episodes of fecal urgency and air in his urine (pneumaturia). CT shows a communication between his ileum and bladder. Which of the following best explains why this complication does NOT occur in ulcerative colitis?
A UC patients have a different anatomic location of inflammation
B UC inflammation is limited to mucosa/submucosa; fistulas require transmural penetration
C UC patients have protective antibiotics
D UC is not a progressive disease
E Smoking in UC prevents fistula formation
Correct: B β€” UC is mucosal/submucosal only
Explanation: Fistula formation requires transmural (full-thickness, all 4 layers) inflammation to breach the bowel wall and allow sinus tracts to adjacent organs. Crohn is transmural β†’ fistulas possible. UC is mucosal + submucosal only β†’ no transmural inflammation β†’ NO fistulas. This is a Crohn-defining feature.
Distractors: Location, antibiotics, disease course, smoking don't explain the histologic difference. Depth of inflammation is key.
Q9
A 51-year-old man with a 6-month history of intermittent lower abdominal pain and change in bowel habits is found to have a left-sided colon cancer on colonoscopy. Imaging is consistent with stage II disease. Which of the following best explains why left-sided CRCs often present at a more advanced stage than right-sided tumors?
A Left colon has better blood supply β†’ faster growth
B Left colon has narrow lumen; annular constriction β†’ obstruction symptoms early, but invasion may be deeper
C Right colon tumors are always polypoid, left are always flat
D Colonoscopy cannot detect left-sided lesions
E Left-sided cancers are associated with IBD; right-sided are sporadic
Correct: B β€” Narrow lumen β†’ early obstruction but deeper invasion
Explanation: Right colon (wide lumen) β†’ exophytic growth β†’ occult bleeding β†’ iron-deficiency anemia (late sign). Left colon (narrow lumen) β†’ annular stricturing ("napkin-ring") β†’ change in bowel habits, obstruction (early symptoms). However, early symptoms don't always mean early stage; the tumor may already be deeply invasive by time of diagnosis.
Distractors: Morphology varies; not inherently different. Colonoscopy is effective for both. IBD is a separate etiology. Blood supply is similar.
Q10
A 68-year-old man presents with severe bloody diarrhea and abdominal distension. Abdominal X-ray shows a dilated colon (8 cm transverse diameter) without perforation. He has a 20-year history of ulcerative colitis. Which of the following management steps is MOST important to avoid in this clinical scenario?
A NPO status and IV fluids
B High-dose IV corticosteroids
C Antidiarrheal agents (loperamide) or opiates
D Broad-spectrum antibiotics for colitis
E Preparation for emergency colectomy
Correct: C β€” Avoid antidiarrheals/opiates
Explanation: This is toxic megacolon (>6 cm dilation + systemic toxicity). Antidiarrheals (loperamide) and opiates INCREASE intraluminal pressure and precipitate perforation. Manage with NPO, IV fluids, corticosteroids, antibiotics, and prepare for emergency colectomy if no improvement in 24–48 hours.
Distractors: All other options are appropriate for toxic megacolon. The trap is medications that worsen motility/pressure, risking perforation.
Clinical Vignette MCQ
Vignette 1
31-year-old male, Ashkenazi Jewish ethnicity, smoker. 2 years of chronic RLQ pain, 8–10 loose stools/day, weight loss 12 lb. Recent perianal drainage. Colonoscopy shows RLQ inflammation with normal-appearing intervening colon segment in mid-colon, then more inflammation in the ascending colon. Biopsy: non-caseating granulomas + transmural lymphoid infiltrate. What is the most likely diagnosis and what is the single most important counseling point regarding modifiable risk?
A UC; smoking protective β†’ continue smoking
B Crohn disease; smoking worsens disease β†’ urgent cessation
C Crohn disease; continue smoking, focus on diet
D BehΓ§et disease; smoking control is key
E Intestinal tuberculosis; treat with standard TB drugs
Correct: B β€” Crohn disease, smoking cessation critical
Why: Skip lesions + non-caseating granulomas + transmural + perianal fistula = Crohn (Ashkenazi Jewish background, NOD2 mutations more common). Smoking worsens Crohn activity and increases surgical recurrence (opposite UC where smoking is protective). Urgent counseling on smoking cessation.
Distractors: Granulomas without caseation rule out TB. UC granulomas absent. Perianal involvement = Crohn, not UC.
Vignette 2
45-year-old woman, 15 years of bloody diarrhea (relapsing-remitting), recent colonoscopy shows continuous friable mucosa from rectum to splenic flexure with pseudopolyps. Biopsy: crypt abscesses, crypt distortion, NO granulomas. She also reports yellowing eyes and right upper quadrant discomfort. What is the most likely complication driving her jaundice?
A Hepatitis B reactivation from immunosuppression
B Primary sclerosing cholangitis (PSC) from UC
C Gallstones from UC-related bile acid dysregulation
D Drug-induced liver injury from 5-ASA
E Adenocarcinoma of the bile ducts
Correct: B β€” Primary sclerosing cholangitis
Why: Continuous colitis from rectum β†’ UC diagnosis confirmed (no granulomas, crypt abscesses). PSC occurs in ~5% of UC patients (rare in Crohn). "Onion-skin" fibrosis β†’ strictures on MRCP/ERCP β†’ cholestasis/jaundice. p-ANCA positive. Elevated cholangiocarcinoma risk; annual colonoscopy for CRC surveillance.
Distractors: Hepatitis B unrelated to UC. Gallstones occur in Crohn (bile acid malabsorption), not a UC-specific complication. 5-ASA hepatotoxicity is rare. Bile duct adenocarcinoma is a complication OF PSC, but PSC itself is the primary driver here.
Vignette 3
72-year-old hospitalized male with recent hip fracture surgery, now on clindamycin for surgical site infection (POD 5). Develops severe watery diarrhea (15 stools/day), fever (38.5Β°C), abdominal pain, WBC 18k. Stool C. difficile GDH and toxin assay both positive. What is the most appropriate initial treatment, and what key mistake should you avoid?
A IV metronidazole + stop clindamycin β†’ reduces antibiotic exposure
B Oral vancomycin or fidaxomicin + stop clindamycin; avoid loperamide
C PO metronidazole + loperamide to reduce diarrhea frequency
D Continue clindamycin + supportive care (watch and wait)
E FMT immediately to restore normal flora
Correct: B β€” Oral vancomycin/fidaxomicin; avoid antidiarrheals
Why: CDI with systemic toxicity (fever, leukocytosis, severe diarrhea). Stop inciting antibiotic (clindamycin). Metronidazole IV does NOT reach colon β†’ ineffective. Vancomycin or fidaxomicin (oral) are first-line. Loperamide/opiates worsen disease β†’ toxic megacolon risk. FMT is for β‰₯2 recurrences.
Distractors: IV metronidazole trap. Continuing clindamycin perpetuates dysbiosis. Antidiarrheals increase pressure/toxin retention.
Vignette 4
64-year-old man with left-sided CRC (stage III) and microsatellite instability-high (MSI-H). Genetic testing reveals MLH1 mutation. His 32-year-old daughter has no CRC symptoms but is interested in screening. What is the most appropriate next step?
A Reassure her; Lynch syndrome only affects older patients
B Routine colonoscopy every 10 years starting age 45
C Genetic counseling + MLH1 testing; if positive, colonoscopy every 1–2 years from age 20–25
D Prophylactic colectomy at age 30
E Chemotherapy as primary prevention
Correct: C β€” Genetic testing + aggressive surveillance
Why: Father with MLH1 mutation = Lynch syndrome. 50% of children are carriers. If daughter inherits mutation β†’ 70–80% lifetime CRC risk, often right-sided/flat adenomas, younger age (average 40–50y). Colonoscopy every 1–2 years starting age 20–25 is standard. Lynch is not autosomal dominant with 100% penetrance in all organs, but CRC risk is very high.
Distractors: Lynch affects young patients. Routine screening (10y intervals) is inadequate. Prophylactic colectomy is for FAP, not Lynch (CRC risk can be managed with surveillance). Chemotherapy is treatment, not prevention.
Vignette 5
58-year-old woman, previously healthy, presents with acute left lower quadrant pain, fever (38.8Β°C), and left-sided abdominal tenderness. CT shows pericolic fat stranding and a 1.5 cm fluid collection near the sigmoid. Stool ova/parasites negative. Labs: WBC 14.5k, mild elevation in CRP. What is the most likely diagnosis, and what is the initial management approach?
A Acute appendicitis; prepare for emergency appendectomy
B Acute diverticulitis with small abscess; IV antibiotics + drainage if needed
C Diverticulitis with Hinchey Grade II abscess; IV ABx + percutaneous drainage + follow-up colonoscopy
D Inflammatory bowel disease; start 5-ASA and corticosteroids
E Infectious colitis; supportive care and antidiarrheals
Correct: C β€” Diverticulitis Grade II; IV ABx + drainage + colonoscopy
Why: Left LLQ pain, fever, pericolic stranding, small abscess (<4 cm) = Hinchey Grade II diverticulitis. Management: IV broad-spectrum antibiotics + percutaneous CT-guided drainage (if abscess >3–4 cm). Follow-up colonoscopy to rule out Crohn/CRC (anatomically similar presentation possible). No emergency surgery needed unless Grade III–IV or failed medical management.
Distractors: Appendicitis is RLQ. IBD would have chronic history/bloody stools. Infectious colitis would have specific pathogens. Antidiarrheals contraindicated.
Classic Step 1 Traps & Confusions
Trap 1
Pseudopolyps in ulcerative colitis indicate early malignant transformation and carry high cancer risk.
TRAP ALERT: This is FALSE. Pseudopolyps are regenerative mucosa between ulcers, NOT adenomas. They do NOT carry cancer risk themselves. Cancer risk in UC comes from flat dysplasia arising in inflamed mucosa, which is why surveillance requires extensive random biopsies (or chromoendoscopy). Pseudopolyps are benign.
Trap 2
In sporadic colorectal cancer, APC mutations occur late in the adenoma-carcinoma sequence.
TRAP ALERT: This is FALSE. In sporadic CRC, APC loss is the FIRST (initiating) event: APC β†’ KRAS β†’ TP53 (classic adenoma-first pathway). "Adenoma" literally means starting with APC. IBD-CRC is the opposite: p53 (early) β†’ KRAS β†’ APC (late). A common USMLE trap is mixing up these sequences.
Trap 3
Metronidazole IV is first-line treatment for C. difficile infection because it has good colonic bioavailability.
TRAP ALERT: This is FALSE. Metronidazole IV does NOT reach therapeutic levels in the colon (it's absorbed in the small bowel). Metronidazole is NO LONGER recommended for CDI. First-line: oral vancomycin or fidaxomicin (non-absorbed, reach colon). This is a classic recent guideline change (2021) that exams test heavily.
Trap 4
Smoking is harmful for all inflammatory bowel disease patients and should be strongly discouraged in both Crohn disease and ulcerative colitis.
TRAP ALERT: Partially FALSE. While smoking should be discouraged for general health, the IBD paradox is that smoking WORSENS Crohn but is PROTECTIVE in UC (opposite effects). The mechanism is unknown, but this paradox is high-yield for exams. Don't encourage smoking in UC, but the exam may ask which IBD is worsened by smoking (answer: Crohn).
Trap 5
Granulomas in intestinal biopsies are specific for Crohn disease and exclude other diagnoses like tuberculosis.
TRAP ALERT: This is FALSE. Granulomas are NOT specific for Crohn. TB can cause granulomas in the terminal ileum and mimic Crohn grossly. KEY DIFFERENCE: Crohn = non-caseating granulomas; TB = CASEATING granulomas with central necrosis. Always perform acid-fast bacillus (AFB) staining when granulomas are found. Sarcoidosis also causes non-caseating granulomas but is systemic (lungs predominate).
Trap 6
Fistulas and perianal abscesses are common complications in both Crohn disease and ulcerative colitis.
TRAP ALERT: This is FALSE. Fistulas (especially perianal) are Crohn-DEFINING and occur in 25–30% of Crohn patients. UC NEVER causes perianal fistulas because UC is mucosal/submucosal only (no transmural penetration needed for sinus tracts). If a patient has UC + perianal fistula, reconsider the diagnosis (likely Crohn). This is a high-yield distinguisher.
Trap 7
Sessile serrated polyps are benign findings with sawtooth histology and do not require aggressive surveillance or resection.
TRAP ALERT: This is FALSE. Sessile serrated polyps are deceptively low-risk-appearing but have HIGH cancer risk because of BRAF mutation + CpG island methylator phenotype (CIMP) β†’ MLH1 silencing β†’ MSI-H. They progress to cancer rapidly despite benign sawtooth histology. Requires aggressive follow-up, complete resection, and consideration of advanced surveillance/ablation.
Trap 8
Right-sided colorectal cancers always present earlier than left-sided cancers because the colon is wider and easier to examine.
TRAP ALERT: This is FALSE. Right-sided CRCs typically present LATE (higher stage) despite earlier iron-deficiency anemia because: wide lumen β†’ exophytic growth β†’ occult bleeding β†’ anemia is late finding. Left-sided present EARLY with obstruction/change in bowel habits (narrow lumen β†’ annular stenosis), but may already be advanced. Wider lumen does NOT equal earlier detection; occult bleeding is a late symptom.
High-Yield Reference Tables
Crohn vs Ulcerative Colitis Comparison
Feature Crohn Disease Ulcerative Colitis
Location Mouth→anus; terminal ileum + RLQ most common Colon only; rectum ALWAYS involved
Distribution Skip lesions (discontinuous) Continuous (no skips)
Depth Transmural (all 4 layers) Mucosa + submucosa only
Gross appearance Cobblestone, creeping fat, strictures, fistulas Friable mucosa, pseudopolyps, lead-pipe colon
Histology Non-caseating granulomas, transmural inflammation Crypt abscesses, NO granulomas
Classic symptom Non-bloody diarrhea, RLQ pain, weight loss Bloody diarrhea + mucus, tenesmus
Complications Strictures, fistulas (perianal, enterovesical), abscesses, B12 deficiency Toxic megacolon, perforation, CRC, PSC
Smoking Worsens disease Protects against disease
Surgery NOT curative (recurs at anastomosis) Colectomy is curative
Serology ASCA+, p-ANCAβˆ’ p-ANCA+, ASCAβˆ’
C. difficile: Diagnosis & Treatment
Aspect Key Point
Organism Gram+ anaerobic spore-former; produces toxins A (enterotoxin) & B (cytotoxin)
Risk factors Clindamycin, cephalosporins, fluoroquinolones, carbapenems, PPIs; healthcare setting
Pseudomembrane "Volcano lesion" = fibrin/neutrophils/epithelial debris; caused by toxin A
Diagnosis (2-step) GDH or NAAT (sensitive) + Toxin EIA (specific for toxigenic strains)
First-line Rx Oral vancomycin or fidaxomicin (NOT IV metronidazoleβ€”does not reach colon)
Recurrence ~25% recur; FMT gold standard for β‰₯2 recurrences (cure >90%)
AVOID Antidiarrheals, opiates (increase toxic megacolon risk)
Adenoma-Carcinoma Sequence: Sporadic vs IBD-Associated
Pathway Sporadic CRC (APC-first) IBD-CRC (p53-first)
Initiating event APC loss (ch 5q) p53 mutation (chronic inflammation)
Intermediate KRAS activation KRAS activation
Late event TP53 loss APC loss
Precursor Adenomatous polyp (polypoid) Flat dysplasia in inflamed mucosa
Age at Dx ~60 years 40–50 years (younger)
Morphology Single, polypoid Multifocal, flat, mucinous/signet-ring
CRC Syndromes: Genetics & Surveillance
Syndrome Genetic Mutation Polyps/Cancer Risk Management
FAP APC (ch 5q) germline 100s–1000s adenomas by age 10–20; 100% cancer by 40 Prophylactic colectomy before age 25
Lynch/HNPCC MLH1, MSH2, MSH6, PMS2 (mismatch repair) MSI-H; 70–80% lifetime CRC risk; right-sided, flat; endometrial #1 extracolonic Colonoscopy every 1–2 years from age 20–25; gynecologic screening
Peutz-Jeghers STK11/LKB1 Hamartomas throughout GI; GI cancer + breast/ovary/pancreas risk ↑↑ Endoscopy surveillance; breast/pancreatic imaging
Juvenile Polyposis SMAD4, BMPR1A Multiple hamartomas; bleeding, intussusception; cancer risk ↑ Surveillance endoscopy; polypectomy for bleeding
Diverticulitis Severity (Hinchey Staging)
Grade Definition Management
0–I Uncomplicated (localized colon inflammation, no abscess) IV antibiotics Β± outpatient (mild), NPO, fluids
II Pericolic or mesenteric abscess <4 cm IV antibiotics + percutaneous CT-guided drainage
III Generalized purulent peritonitis (perforation) Emergency surgery; Hartmann procedure or resection
IV Fecal peritonitis Emergency surgery; highest mortality
IBD Extraintestinal Manifestations
Manifestation Both IBD Types Crohn-Specific UC-Linked
Skin Erythema nodosum, pyoderma gangrenosum β€” β€”
Eyes Uveitis, episcleritis β€” β€”
Joints Peripheral arthritis, ankylosing spondylitis (HLA-B27) β€” β€”
GI β€” Perianal fistulas/abscesses, B12 deficiency, oxalate stones Toxic megacolon, PSC, ↑↑ CRC
Hepatobiliary β€” Gallstones (bile acid malabsorption) PSC (5%), ↑ cholangiocarcinoma